top of page

Téléphone : +918866862020

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Bilypsa Tablet 10's

Bilypsa Tablet 10's

Manufacturer/Marketed By : ZYDUS CADILA

$5.34 $4.54

Bilypsa tablet is an antidiabetic drug contains an active ingredient called Saroglitazar. It belongs to the medication class known as a dual peroxisome proliferator-activated receptor (PPAR) agonist. It is used...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

SAROGLITAZAR

Active Pharmaceutical Ingredient

Bilypsa Tablet 10's

SKU ZYDUS CADILA
Prix d’origine

5,34 $US

Prix promotionnel

4,54 $US

Bilypsa tablet is an antidiabetic drug contains an active ingredient called Saroglitazar. It belongs to the medication class known as a dual peroxisome proliferator-activated receptor (PPAR) agonist. It is used to treat diabetic dyslipidemia (an abnormal amount of lipids in the blood) and hypertriglyceridemia (high level of triglycerides in the blood) in patients with type 2 diabetes mellitus that is not controlled by statin therapy. Bilypsa tablets should not be consumed if you are allergic to Saroglitazar or any of its ingredients in the medication. Before taking this medicine, inform your doctor if you have liver or kidney issues or a history of muscle problems. This medicine has not been studied in severe heart failure patients, so caution is needed in those with heart disease. Although weight gain and oedema are uncommon, if you rapidly gain weight, watch for swelling and heart failure symptoms. The safety and effectiveness of the Bilypsa tablet have not been confirmed for use in children. Before starting the treatment, inform your doctor if you are pregnant, think you may be pregnant, or planning to get pregnant or breastfeeding.

Active Pharmaceutical Ingredient

SAROGLITAZAR

Uses

• Treats diabetic dyslipidemia (an abnormal amount of lipids in the blood)
• Hypertriglyceridemia (high level of triglycerides in the blood)

Benefits

Bilypsa tablet works by managing high cholesterol and triglycerides, along with blood sugar levels in type 2 diabetes. Its unique mechanism reduces the synthesis and secretion of triglycerides, improving insulin sensitivity for better utilization and lowering blood sugar levels.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

Most Common Side Effects

Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.

Common Side Effects

• Gastritis (stomach inflammation)
• Nausea
• Vomiting
• Asthenia (weakness)
• Chest discomfort
• Dizziness
• Fever
• Weakness

How To Use

Take the Bilypsa tablet as your physician advises. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.

Safety Advice

• Breast Feeding: It is unknown whether Bilypsa tablet is excreted in breast milk. So, before starting the treatment, inform your doctor if you are breastfeeding. Contact your doctor for more information. Your doctor will suggest this medicine only if needed.
• Alcohol: Do not consume alcohol while taking the Bilypsa tablet. Please speak with your physician for more information.
• Liver: Bilypsa tablet should be used cautiously in liver patients. Before starting the treatment, inform your physician about pre-existing liver conditions.
• Lungs: It is unknown whether Bilypsa tablet is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
• Driving: It is unknown whether Bilypsa tablet alters driving ability. However, if you experience side effects like tiredness or drowsiness, avoid driving and using machines.
• Pregnancy: Limited information is available on using Bilypsa tablets during pregnancy. Notify your healthcare professional if you are pregnant or planning to have a baby think you may be pregnant. Your doctor will suggest this medicine only if needed.

Disclaimer

Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.

Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.

Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.

Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.

bottom of page